Cansino Biologics Inc Net Asset Quality Index
Cansino Biologics Inc net asset quality index. Cansino Biologics Inc (688185) has a Net Asset Quality Index of 168.7% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥7.18 Billion minus total liabilities of CN¥-4.93 Billion yields net assets of CN¥12.11 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check 688185 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Cansino Biologics Inc (2016–2025)
Net asset quality index of Cansino Biologics Inc from 2016 to 2025. This chart shows how Cansino Biologics Inc's Net Asset Quality Index has evolved across 10 annual periods from 2016 to 2025. As of December 2025, the index stands at 168.7%, representing net assets of CN¥12.11 Billion against total assets of CN¥7.18 Billion CNY. See 688185 total equity for net asset value and shareholders' equity analysis.
Cansino Biologics Inc Net Asset Quality Index by Year (2016–2025)
Cansino Biologics Inc net asset quality index by year from 2016 to 2025. The table below presents the year-by-year Net Asset Quality Index for Cansino Biologics Inc from 2016 to 2025, covering 10 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Cansino Biologics Inc market capitalisation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 168.7% | CN¥12.11 Billion | CN¥7.18 Billion | CN¥-4.93 Billion | ▲ +107.0 pp |
| 2024 | 61.7% | CN¥4.92 Billion | CN¥7.96 Billion | CN¥3.05 Billion | ▲ +5.0 pp |
| 2023 | 56.7% | CN¥5.29 Billion | CN¥9.32 Billion | CN¥4.03 Billion | ▼ -6.4 pp |
| 2022 | 63.2% | CN¥7.25 Billion | CN¥11.47 Billion | CN¥4.22 Billion | ▼ -8.8 pp |
| 2021 | 72.0% | CN¥8.55 Billion | CN¥11.87 Billion | CN¥3.33 Billion | ▼ -18.0 pp |
| 2020 | 90.0% | CN¥6.07 Billion | CN¥6.75 Billion | CN¥677.22 Million | ▲ +7.6 pp |
| 2019 | 82.4% | CN¥1.47 Billion | CN¥1.78 Billion | CN¥313.98 Million | ▲ +19.3 pp |
| 2018 | 63.1% | CN¥502.32 Million | CN¥795.88 Million | CN¥293.56 Million | ▼ -7.0 pp |
| 2017 | 70.1% | CN¥607.33 Million | CN¥866.36 Million | CN¥259.03 Million | ▲ +4.3 pp |
| 2016 | 65.8% | CN¥214.47 Million | CN¥326.17 Million | CN¥111.70 Million | — |